Farletuzumab

Farletuzumab (MORAb-003) is a potent folate receptor-alpha (FRα) inhibitor. Farletuzumab is a humanized monoclonal antibody with high affinity for FRα. Farletuzumab possesses growth-inhibitory functions on cells overexpressing FRα. Farletuzumab can be used in research of cancer[1].

Product Specifications

CAS Number

[896723-44-7]

Product Name Alternative

MORAb-003

UNSPSC

12352203

Target

Antibiotic

Type

Inhibitory Antibodies

Related Pathways

Anti-infection

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/farletuzumab.html

Purity

99.00

Solubility

10 mM in DMSO

Smiles

[Farletuzumab]

Molecular Weight

(145.36 kDa)

References & Citations

[1]Ebel W, et, al. Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha. Cancer Immun. 2007 Mar 9;7:6.